PL2935312T3 - Peptydy jako agoniści oksytocyny - Google Patents

Peptydy jako agoniści oksytocyny

Info

Publication number: PL2935312T3
Authority: PL; Poland
Prior art keywords: peptides; oxytocin agonists; oxytocin; agonists
Prior art date: 2012-12-21

Application number

PL13814079T

Other languages

English (en)

Inventor

Caterina Bissantz

Konrad Bleicher

Christophe Grundschober

Original Assignee

F.Hoffmann-La Roche Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-21

Filing date

2013-12-17

Publication date

2018-12-31

2013-12-17 Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag

2018-12-31 Publication of PL2935312T3 publication Critical patent/PL2935312T3/pl

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

PL13814079T 2012-12-21 2013-12-17 Peptydy jako agoniści oksytocyny PL2935312T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP12199012		2012-12-21
PCT/EP2013/076783 WO2014095773A1 (en)	2012-12-21	2013-12-17	Peptides as oxytocin agonists
EP13814079.3A EP2935312B1 (en)	2012-12-21	2013-12-17	Peptides as oxytocin agonists

Publications (1)

Publication Number	Publication Date
PL2935312T3 true PL2935312T3 (pl)	2018-12-31

Family

ID=47471593

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL13814079T PL2935312T3 (pl)	2012-12-21	2013-12-17	Peptydy jako agoniści oksytocyny

Country Status (34)

Country	Link
US (1)	US9868766B2 (pl)
EP (1)	EP2935312B1 (pl)
JP (1)	JP6067878B2 (pl)
KR (1)	KR101819804B1 (pl)
CN (1)	CN104870466B (pl)
AR (1)	AR094225A1 (pl)
AU (1)	AU2013363768B2 (pl)
BR (1)	BR112015014010A2 (pl)
CA (1)	CA2895150C (pl)
CL (1)	CL2015001724A1 (pl)
CR (1)	CR20150271A (pl)
DK (1)	DK2935312T3 (pl)
EA (1)	EA026687B1 (pl)
ES (1)	ES2690317T3 (pl)
HK (1)	HK1208477A1 (pl)
HR (1)	HRP20181569T1 (pl)
HU (1)	HUE039848T2 (pl)
IL (1)	IL239519A (pl)
LT (1)	LT2935312T (pl)
MA (1)	MA38272A1 (pl)
MX (1)	MX358684B (pl)
MY (1)	MY176398A (pl)
NZ (1)	NZ708175A (pl)
PE (1)	PE20151446A1 (pl)
PH (1)	PH12015501145A1 (pl)
PL (1)	PL2935312T3 (pl)
PT (1)	PT2935312T (pl)
RS (1)	RS57690B1 (pl)
SG (1)	SG11201504883PA (pl)
SI (1)	SI2935312T1 (pl)
TW (1)	TWI558726B (pl)
UA (1)	UA119034C2 (pl)
WO (1)	WO2014095773A1 (pl)
ZA (1)	ZA201504186B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10039777B2 (en)	2012-03-20	2018-08-07	Neuro-Lm Sas	Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
KR102168621B1 (ko)	2012-12-21	2020-10-22	얀센 바이오파마, 인코퍼레이트.	치환된 뉴클레오사이드, 뉴클레오타이드 및 그것의 유사체
LT2935312T (lt)	2012-12-21	2018-10-25	F. Hoffmann-La Roche Ag	Peptidai, kaip oksitocino agonistai
UA111305C2 (uk)	2012-12-21	2016-04-11	Пфайзер Інк.	Конденсовані лактами арилу та гетероарилу
KR102116107B1 (ko)	2013-12-30	2020-05-28	삼성디스플레이 주식회사	표시 장치
US9988421B2 (en)	2014-01-10	2018-06-05	Cornell University	Dipeptides as inhibitors of human immunoproteasomes
CN106414479B (zh)	2014-06-03	2021-08-03	豪夫迈·罗氏有限公司	作为催产素激动剂的肽
CR20160574A (es)	2014-06-17	2017-02-23	Pfizer	Compuestos de dihidroisoquinolinona sustituida
US10588980B2 (en)	2014-06-23	2020-03-17	Novartis Ag	Fatty acids and their use in conjugation to biomolecules
WO2016020349A1 (en) *	2014-08-07	2016-02-11	F. Hoffmann-La Roche Ag	Processes for the preparation of oxytocin analogues
US11202817B2 (en)	2014-08-18	2021-12-21	Cornell University	Dipeptidomimetics as inhibitors of human immunoproteasomes
WO2016044131A1 (en)	2014-09-19	2016-03-24	Ferring B.V.	Method of treating prader-willi syndrome
EP3362754B1 (en)	2015-10-15	2021-12-22	Cornell University	Proteasome inhibitors and uses thereof
US11203613B2 (en)	2017-10-11	2021-12-21	Cornell University	Peptidomimetic proteasome inhibitors
KR20210062648A (ko)	2018-09-20	2021-05-31	레보 테라퓨틱스 인코포레이티드	카르베토신 완제의약품 및 이를 제조하는 방법
US20200093884A1 (en)	2018-09-20	2020-03-26	Mark C. Manning	Stable intranasal formulations of carbetocin
WO2021126990A1 (en) *	2019-12-16	2021-06-24	The Scripps Research Institute	Oxytocin derivatives with improved properties

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2010010743A (es)	2008-03-31	2010-11-04	Ferring Bv	Analogos de oxitocina.
TWI463990B (zh)	2009-09-21	2014-12-11	Ferring Bv	催產素受體促進劑
AU2010302945B2 (en) *	2009-10-01	2015-09-24	The University Of Sydney	Therapy and prevention of problem drinking
LT2935312T (lt)	2012-12-21	2018-10-25	F. Hoffmann-La Roche Ag	Peptidai, kaip oksitocino agonistai

2013
- 2013-12-17 LT LTEP13814079.3T patent/LT2935312T/lt unknown
- 2013-12-17 DK DK13814079.3T patent/DK2935312T3/en active
- 2013-12-17 RS RS20181124A patent/RS57690B1/sr unknown
- 2013-12-17 CN CN201380066617.7A patent/CN104870466B/zh not_active Expired - Fee Related
- 2013-12-17 EA EA201591078A patent/EA026687B1/ru not_active IP Right Cessation
- 2013-12-17 PL PL13814079T patent/PL2935312T3/pl unknown
- 2013-12-17 MX MX2015007365A patent/MX358684B/es active IP Right Grant
- 2013-12-17 SI SI201331190T patent/SI2935312T1/sl unknown
- 2013-12-17 SG SG11201504883PA patent/SG11201504883PA/en unknown
- 2013-12-17 PT PT13814079T patent/PT2935312T/pt unknown
- 2013-12-17 CA CA2895150A patent/CA2895150C/en not_active Expired - Fee Related
- 2013-12-17 ES ES13814079.3T patent/ES2690317T3/es active Active
- 2013-12-17 HU HUE13814079A patent/HUE039848T2/hu unknown
- 2013-12-17 NZ NZ708175A patent/NZ708175A/en not_active IP Right Cessation
- 2013-12-17 MA MA38272A patent/MA38272A1/fr unknown
- 2013-12-17 WO PCT/EP2013/076783 patent/WO2014095773A1/en active Application Filing
- 2013-12-17 UA UAA201506906A patent/UA119034C2/uk unknown
- 2013-12-17 MY MYPI2015001585A patent/MY176398A/en unknown
- 2013-12-17 EP EP13814079.3A patent/EP2935312B1/en active Active
- 2013-12-17 JP JP2015548420A patent/JP6067878B2/ja not_active Expired - Fee Related
- 2013-12-17 KR KR1020157016376A patent/KR101819804B1/ko active IP Right Grant
- 2013-12-17 AU AU2013363768A patent/AU2013363768B2/en not_active Ceased
- 2013-12-17 PE PE2015001058A patent/PE20151446A1/es unknown
- 2013-12-17 BR BR112015014010A patent/BR112015014010A2/pt not_active IP Right Cessation
- 2013-12-20 TW TW102147655A patent/TWI558726B/zh not_active IP Right Cessation
- 2013-12-20 AR ARP130104962A patent/AR094225A1/es unknown
2015
- 2015-05-21 CR CR20150271A patent/CR20150271A/es unknown
- 2015-05-22 PH PH12015501145A patent/PH12015501145A1/en unknown
- 2015-06-10 ZA ZA2015/04186A patent/ZA201504186B/en unknown
- 2015-06-18 US US14/743,009 patent/US9868766B2/en active Active
- 2015-06-18 IL IL239519A patent/IL239519A/en active IP Right Grant
- 2015-06-18 CL CL2015001724A patent/CL2015001724A1/es unknown
- 2015-09-18 HK HK15109189.5A patent/HK1208477A1/xx not_active IP Right Cessation
2018
- 2018-10-02 HR HRP20181569TT patent/HRP20181569T1/hr unknown

Also Published As

Publication number	Publication date
LT2935312T (lt)	2018-10-25
SI2935312T1 (sl)	2018-11-30
CA2895150C (en)	2019-11-26
JP6067878B2 (ja)	2017-01-25
DK2935312T3 (en)	2018-10-22
AR094225A1 (es)	2015-07-22
AU2013363768B2 (en)	2016-02-04
BR112015014010A2 (pt)	2017-07-11
RS57690B1 (sr)	2018-11-30
KR101819804B1 (ko)	2018-01-17
CN104870466B (zh)	2018-05-18
TWI558726B (zh)	2016-11-21
WO2014095773A1 (en)	2014-06-26
KR20150085845A (ko)	2015-07-24
JP2016503044A (ja)	2016-02-01
NZ708175A (en)	2020-06-26
CN104870466A (zh)	2015-08-26
EA201591078A1 (ru)	2015-10-30
EA026687B1 (ru)	2017-05-31
MX358684B (es)	2018-08-31
TW201429994A (zh)	2014-08-01
HUE039848T2 (hu)	2019-02-28
CA2895150A1 (en)	2014-06-26
MX2015007365A (es)	2015-10-14
UA119034C2 (uk)	2019-04-25
CL2015001724A1 (es)	2015-10-16
PT2935312T (pt)	2018-10-26
HRP20181569T1 (hr)	2018-11-30
PH12015501145B1 (en)	2015-08-10
SG11201504883PA (en)	2015-07-30
MY176398A (en)	2020-08-05
MA38272A1 (fr)	2017-07-31
IL239519A (en)	2017-06-29
PE20151446A1 (es)	2015-09-28
ES2690317T3 (es)	2018-11-20
PH12015501145A1 (en)	2015-08-10
US9868766B2 (en)	2018-01-16
HK1208477A1 (en)	2016-03-04
EP2935312B1 (en)	2018-08-08
ZA201504186B (en)	2016-04-28
EP2935312A1 (en)	2015-10-28
US20150284434A1 (en)	2015-10-08
CR20150271A (es)	2015-08-28
IL239519A0 (en)	2015-08-31
AU2013363768A1 (en)	2015-06-04

Publication	Publication Date	Title
HRP20181569T1 (hr)	2018-11-30	Peptidi kao agonisti oksitocina
EP2857033A4 (en)	2016-03-30	SKIN-PUNKING PEPTIDE
HK1204797A1 (en)	2015-12-04	Novel anti-siglec15 antibody -siglec-15
EP2812347A4 (en)	2015-11-04	AUTOPHAGIA-INDUCING PEPTIDE
EP2848687A4 (en)	2015-12-02	NOVEL EXPRESSION VECTOR
GB201218813D0 (en)	2012-12-05	Antimicrobial peptides
HK1211486A1 (en)	2016-05-27	Novel uses
GB201220119D0 (en)	2012-12-26	Vector
EP2865686A4 (en)	2016-04-13	EGFR-BINDING PEPTIDE
HK1209138A1 (en)	2016-03-24	Peptides
GB201204868D0 (en)	2012-05-02	Peptides
GB201200555D0 (en)	2012-02-29	Peptide
GB201223114D0 (en)	2013-02-06	Novel peptide
GB201205795D0 (en)	2012-05-16	Vector
GB201201720D0 (en)	2012-03-14	Novel combinations
HUE036243T2 (hu)	2018-06-28	PSF1-származék peptid
HK1201752A1 (en)	2015-09-11	Alternaria peptides
GB201214413D0 (en)	2012-09-26	Festivalstand (festistand)
GB201304493D0 (en)	2013-04-24	Not published
GB201213672D0 (en)	2012-09-12	Protein
GB201220328D0 (en)	2012-12-26	Peptides
GB201211740D0 (en)	2012-08-15	Peptides
GB201207895D0 (en)	2012-06-20	Peptides
GB201200509D0 (en)	2012-02-22	Peptides
GB201221414D0 (en)	2013-01-09	Trans-locating peptide